Does rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome? : Evidence-Based Practice

Secondary Logo

Journal Logo

Advanced Search

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid
HELPDESK ANSWERS

Does rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome?

Wright, Kent MD; Middleton, Paul MD; Hudson, Jonell PharmD, BCPS; Coulter, Lois PharmD, BCPS; Vaughn, Brittany MD

Author Information

UAMS Northwest FMR, Fayetteville, AR

The authors declare no conflicts of interest.

doi: 10.1097/EBP.0000000000001333
  • Buy
Copyright © 2021 by Family Physicians Inquiries Network, Inc.